Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
29
Number of overlapping holdings
70.7%
% of GNOM's 41 holdings also in WDNA
32.6%
% of WDNA's 91 holdings also in GNOM
Overlap by Weight
Sector Drift (GNOM minus WDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in GNOM |
Weight in WDNA |
Overlap | |
|---|---|---|---|---|
 |
NATERA INC | 7.4% | 1.9% | 1.9% |
|
CRISPR THERAPEUTICS AG | 4.9% | 1.8% | 1.8% |
|
ULTRAGENYX PHARMACEUTICAL IN | 4.7% | 1.6% | 1.6% |
|
BEAM THERAPEUTICS, INC. | 3.2% | 1.4% | 1.4% |
|
VERTEX PHARMACEUTICALS INC | 1.7% | 1.3% | 1.3% |
Position Highlights (Non-Overlapping Exposures)
GNOM Overweight Relative to WDNA
 |
ENI SPA-SPONSORED ADR | 7.2% |
|
NATERA INC | 5.5% |
|
MODERNA, INC. | 3.5% |
|
AGILENT TECHNOLOGIES INC | 3.2% |
|
ROCKET PHARMACEUTICALS, INC. | 3.2% |
|
CRISPR THERAPEUTICS AG | 3.2% |
|
ULTRAGENYX PHARMACEUTICAL IN | 3.2% |
|
AVIDITY BIOSCIENCES INC | 3.0% |
|
ILLUMINA INC | 2.8% |
|
LEGEND BIOTECH CORPORATION SPONSORED | 2.6% |
GNOM Underweight Relative to WDNA
|
IOVANCE BIOTHERAPEUTICS INC | -3.9% |
|
TWIST BIOSCIENCE CORP. | -3.4% |
|
FATE THERAPEUTICS INC | -3.1% |
 |
NOVOZYMES A/S-B SHARES | -2.4% |
|
BLUEPRINT MEDICINES CORP. | -2.2% |
|
BRIDGEBIO PHARMA, INC. | -2.0% |
|
ELI LILLY & CO | -1.9% |
 |
ALCOBRA LTD | -1.7% |
|
VERICEL CORPORATION | -1.7% |
|
AGIOS PHARMACEUTICALS INC | -1.6% |